ID  Description  P-value  P.adjust  Count
hsa05167  Kaposi sarcoma-associated herpesvirus infection  5.39E-16  8.46E-14  13
hsa04933  AGE-RAGE signaling pathway in diabetic complications  1.13E-15  8.85E-14  11
hsa05163  Human cytomegalovirus infection  6.58E-15  3.45E-13  13
hsa04657  IL-17 signaling pathway  4.27E-14  1.68E-12  10
hsa05161  Hepatitis B  2.60E-13  6.81E-12  11
hsa04668  TNF signaling pathway  2.60E-13  6.81E-12  10
hsa05164  Influenza A  1.78E-11  4.00E-10  10
hsa05133  Pertussis  2.57E-11  5.04E-10  8
hsa05152  Tuberculosis  3.16E-11  5.50E-10  10
hsa05169  Epstein-Barr virus infection  9.46E-11  1.48E-09  10
hsa05170  Human immunodeficiency virus 1 infection  1.60E-10  2.29E-09  10
hsa05142  Chagas disease (American trypanosomiasis)  2.86E-10  3.74E-09  8
hsa05140  Leishmaniasis  1.57E-09  1.90E-08  7
hsa04210  Apoptosis  2.89E-09  3.24E-08  8
hsa05162  Measles  3.24E-09  3.40E-08  8
hsa05132  Salmonella infection  4.64E-09  4.55E-08  9
hsa01522  Endocrine resistance  8.69E-09  8.03E-08  7
hsa04625  C-type lectin receptor signaling pathway  1.32E-08  1.15E-07  7
hsa05145  Toxoplasmosis  2.22E-08  1.83E-07  7
hsa05130  Pathogenic Escherichia coli infection  6.53E-08  5.13E-07  8